SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENIC-PATIENTS - NORMALIZATION AFTER NEUROLEPTIC TREATMENT

被引：0

作者：

WIDERLOV, E

LINDSTROM, LH

BESEV, G

MANBERG, PJ

NEMEROFF, CB

BREESE, GR

KIZER, JS

PRANGE, AJ

机构：

[1] UNIV N CAROLINA,SCH MED,DEPT PSYCHIAT,CHAPEL HILL,NC 27514

[2] UNIV N CAROLINA,SCH MED,DEPT MED,CHAPEL HILL,NC 27514

[3] UNIV N CAROLINA,SCH MED,PROGRAM NEUROBIOL,CHAPEL HILL,NC 27514

[4] UNIV N CAROLINA,SCH MED,BIOL SCI RES CTR,CHAPEL HILL,NC 27514

[5] UNIV UPPSALA,PSYCHIAT RES CTR,S-75105 UPPSALA,SWEDEN

[6] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 1982年 / 139卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：1122 / 1126

页数：5

共 50 条

[21] DRUG LEVELS AND ANTIPARKINSONIAN DRUGS IN NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS
HITRI, A
CRAFT, RB
SETHI, R
SINHA, D
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) : 261 - 271
[22] PLASMA-LEVELS OF NEUROLEPTIC DRUGS AND EXTRAPYRAMIDAL SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
BLOEINK, M
BERGENER, M
HESSE, C
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 833 - 833
[23] SERUM NEUROLEPTIC AND PROLACTIN LEVELS IN SCHIZOPHRENIC-PATIENTS AND CLINICAL-RESPONSE
MELTZER, HY
BUSCH, DA
FANG, VS
PSYCHIATRY RESEARCH, 1983, 9 (04) : 271 - 283
[24] CHLORPROMAZINE LEVELS AND THE OUTCOME OF TREATMENT IN SCHIZOPHRENIC-PATIENTS
MAY, PRA
VANPUTTEN, T
JENDEN, DJ
YALE, C
DIXON, WJ
ARCHIVES OF GENERAL PSYCHIATRY, 1981, 38 (02) : 202 - 207
[25] TASK-RELATED EEG ALPHA ASYMMETRY IN SCHIZOPHRENIC-PATIENTS PRIOR TO AND AFTER NEUROLEPTIC TREATMENT
MERRIN, EL
FLOYD, TC
FEIN, G
SCHIZOPHRENIA RESEARCH, 1988, 1 (04) : 283 - 293
[26] NEUROLEPTIC TREATMENT AND OTHER FACTORS MODIFYING CANCER RISK IN SCHIZOPHRENIC-PATIENTS
MORTENSEN, PB
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (06) : 585 - 590
[27] NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIC-PATIENTS - A REVIEW OF THE LITERATURE
GILBERT, PL
HARRIS, MJ
MCADAMS, LA
JESTE, DV
ARCHIVES OF GENERAL PSYCHIATRY, 1995, 52 (03) : 173 - 188
[28] SOMATOSTATIN IN THE CEREBROSPINAL-FLUID OF SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER NEUROLEPTIC DRUG-TREATMENT
HEIKKILA, L
SCHIZOPHRENIA RESEARCH, 1993, 8 (03) : 273 - 277
[29] DEXAMETHASONE SUPPRESSION TEST IN SCHIZOPHRENIC-PATIENTS BEFORE AND DURING NEUROLEPTIC TREATMENT
WIK, G
WIESEL, FA
ENEROTH, P
SEDVALL, G
ASTROM, G
ACTA PSYCHIATRICA SCANDINAVICA, 1986, 74 (02) : 161 - 167
[30] NEUROLEPTIC TREATMENT AND OTHER FACTORS MODIFYING CANCER RISK IN SCHIZOPHRENIC-PATIENTS
RAVN, J
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 76 (05) : 605 - 605

← 1 2 3 4 5 →